Literature DB >> 10408377

Decay acceleration of the complement alternative pathway C3 convertase.

D E Hourcade1, L M Mitchell, M E Medof.   

Abstract

An ELISA-based method is described for analyzing the mechanism by which the decay of the alternative pathway C3 convertase is accelerated by C3 regulatory proteins. Using this assay, we show that human decay-accelerating factor (DAF) and factor H are active on mature convertase complexes (C3bBb) but not on their nascent precursor (C3bB). This finding has implications on the mechanisms of action of these two regulators. The complement convertases cleave the serum protein C3, and the resulting C3b activation fragments covalently attach to nearby targets where they direct antigen selection, immune clearance, and cell lysis. Several proteins, including the membrane protein DAF, and the serum protein factor H, limit convertase activity by promoting their irreversible dissociation. An understanding of the biochemical mechanisms providing for their activities would be helpful for the therapeutic control of the complement response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408377     DOI: 10.1016/s0162-3109(99)00005-3

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  13 in total

1.  Complement regulation at the molecular level: the structure of decay-accelerating factor.

Authors:  P Lukacik; P Roversi; J White; D Esser; G P Smith; J Billington; P A Williams; P M Rudd; M R Wormald; D J Harvey; M D M Crispin; C M Radcliffe; R A Dwek; D J Evans; B P Morgan; R A G Smith; S M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

2.  NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.

Authors:  Siao-Yi Wang; Emilian Racila; Ronald P Taylor; George J Weiner
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

3.  The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.

Authors:  Masashi Sakuma; Toshifumi Morooka; Yunmei Wang; Can Shi; Kevin Croce; Huiyun Gao; Michael Strainic; M Edward Medof; Daniel I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

4.  Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.

Authors:  Serena Bettoni; Elena Bresin; Giuseppe Remuzzi; Marina Noris; Roberta Donadelli
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

5.  Cell surface complement regulators moderate experimental myasthenia gravis pathology.

Authors:  Linda L Kusner; Jose A Halperin; Henry J Kaminski
Journal:  Muscle Nerve       Date:  2012-10-05       Impact factor: 3.217

6.  Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.

Authors:  Nirmal K Banda; Brandt Levitt; Magdalena J Glogowska; Joshua M Thurman; Kazue Takahashi; Gregory L Stahl; Stephen Tomlinson; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

7.  Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.

Authors:  Federico Forneris; Jin Wu; Xiaoguang Xue; Daniel Ricklin; Zhuoer Lin; Georgia Sfyroera; Apostolia Tzekou; Elena Volokhina; Joke Cm Granneman; Richard Hauhart; Paula Bertram; M Kathryn Liszewski; John P Atkinson; John D Lambris; Piet Gros
Journal:  EMBO J       Date:  2016-03-24       Impact factor: 11.598

8.  Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.

Authors:  Suzan H M Rooijakkers; Jin Wu; Maartje Ruyken; Robert van Domselaar; Karel L Planken; Apostolia Tzekou; Daniel Ricklin; John D Lambris; Bert J C Janssen; Jos A G van Strijp; Piet Gros
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606

9.  Human factor H-related protein 2 (CFHR2) regulates complement activation.

Authors:  Hannes U Eberhardt; Denise Buhlmann; Peter Hortschansky; Qian Chen; Sascha Böhm; Markus J Kemper; Reinhard Wallich; Andrea Hartmann; Teresia Hallström; Peter F Zipfel; Christine Skerka
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

10.  Saliva of Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) inhibits classical and alternative complement pathways.

Authors:  Naylene C S Silva; Vladimir F Vale; Paula F Franco; Nelder F Gontijo; Jesus G Valenzuela; Marcos H Pereira; Mauricio R V Sant'Anna; Daniel S Rodrigues; Walter S Lima; Blima Fux; Ricardo N Araujo
Journal:  Parasit Vectors       Date:  2016-08-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.